Monday, 25 January 2016

Gastro-oesophageal reflux disease

Condition: GORD

Definition:

  • Extremely common 

Main features:

  • Nausea
  • Bloating and belching 
  • Heartburn 
  • Acid regurgitation, especially lying down at night 
  • Water brash
  • Nocturnal cough with possible asthma like symptoms 
  • Diagnosis usually made on history 
  • investigation usually not needed unless red flag features present
Red flag features


  • Anaemia 
  • Dysphagia 
  • Odynophagia (painful swallowing)
  • Haematemesis or melaena 
  • Unexplained weight loss > 10%
  • Vomiting 
  • Older age > 50 years 
  • Chronic NSAID use
  • Severe symptoms
  • Family history of upper GIT or colorectal cancer
  • short history of symptoms 
Investigations
  • Gastroscopy (around 2/3 patients have normal gastroscopy)

Murtagh's diagnostic triad

Management plan:


  • If mild intermittent symptom (no more than once per week), trial of lifestyle management first:
    • weight reduction 
    • eating smaller meals 
    • drinking most fluid between meals rather than with them
    • avoiding lying down after eating 
    • avoid eating or drinking 2 to 3 hours before bedtime or vigorous exercise
    • elevating the bedhead
    • losing weight 
    • Stopping smoking 
    • Decreasing alcohol consumption 
  • Pharmacological intervention 
    • MgOH + Aluminium hydroxider preparations 10 to 20 ml orally 
    • antacid plus alginate prepartions 10 to 20 ml orally 
    • A histamine h2 receptor antagonist e.g. ranitidine 150 mg once or twice daily 
    • PPI 
    • Fail to respond to PPI after 8 weeks warrants further investigation
    • If moderate to severe symptoms (twice or more per week) --> start on PPI
  • Maintenance therapy
    • try stopping PPI (30% of people have prolonged remission of symptoms)
    • step down to the lowest dose possible 
    • NPS has an educational module on how to stop PPIs. 
    • PPIs are fairly safe to use but the safety profile in long term use is uncertain. Some potential side effects associated with long term use include: fracture, increase enterc infection, vitamin b12 deficieny, iron and magnesium deficiency and pneumonia. (Please see reference 3) 
References:
  • John Murtagh's general practice 5th edition 
  • eTG 
  • http://www.nps.org.au/publications/health-professional/medicinewise-news/2015/proton-pump-inhibitors


No comments:

Post a Comment